Transforming Translation Through Quantitative Pharmacology for High-Impact Decision Making in Drug Discovery and Development

Clin Pharmacol Ther. 2020 Jun;107(6):1285-1289. doi: 10.1002/cpt.1667. Epub 2019 Nov 10.

Authors

Affiliations

¹ Millennium Pharmaceuticals, Inc. (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited), Cambridge, Massachusetts, USA.
² Uppsala University, Uppsala, Sweden.
³ Pfizer Inc, Cambridge, Massachusetts, USA.
⁴ Merck & Co., Inc, Kenilworth, New Jersey, USA.
⁵ Sanofi, Bridgewater, New Jersey, USA.
⁶ Servier, Suresnes, France.
⁷ Theravance Biopharma US, Inc., South San Francisco, California, USA.

PMID: 31709519
DOI: 10.1002/cpt.1667

No abstract available

MeSH terms

Decision Making
Drug Development / methods*
Drug Discovery / methods*
Humans
Pharmacology
Translational Research, Biomedical / methods*